GB0107837D0 - Biological materials and methods for use in the prevention or treatment of infections:II - Google Patents

Biological materials and methods for use in the prevention or treatment of infections:II

Info

Publication number
GB0107837D0
GB0107837D0 GB0107837A GB0107837A GB0107837D0 GB 0107837 D0 GB0107837 D0 GB 0107837D0 GB 0107837 A GB0107837 A GB 0107837A GB 0107837 A GB0107837 A GB 0107837A GB 0107837 D0 GB0107837 D0 GB 0107837D0
Authority
GB
United Kingdom
Prior art keywords
infections
prevention
treatment
methods
biological materials
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GB0107837A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ip2ipo Innovations Ltd
Original Assignee
Imperial College Innovations Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Imperial College Innovations Ltd filed Critical Imperial College Innovations Ltd
Priority to GB0107837A priority Critical patent/GB0107837D0/en
Publication of GB0107837D0 publication Critical patent/GB0107837D0/en
Priority to EP02720132A priority patent/EP1372709A2/en
Priority to AU2002251202A priority patent/AU2002251202A1/en
Priority to PCT/GB2002/001462 priority patent/WO2002079247A2/en
Priority to AU2002241162A priority patent/AU2002241162A1/en
Priority to PCT/GB2002/001447 priority patent/WO2002079240A2/en
Ceased legal-status Critical Current

Links

GB0107837A 2001-03-29 2001-03-29 Biological materials and methods for use in the prevention or treatment of infections:II Ceased GB0107837D0 (en)

Priority Applications (6)

Application Number Priority Date Filing Date Title
GB0107837A GB0107837D0 (en) 2001-03-29 2001-03-29 Biological materials and methods for use in the prevention or treatment of infections:II
EP02720132A EP1372709A2 (en) 2001-03-29 2002-03-26 Intimins for the prevention or treatment of infections: i
AU2002251202A AU2002251202A1 (en) 2001-03-29 2002-03-26 Intimins for the prevention or treatment of infections: i
PCT/GB2002/001462 WO2002079247A2 (en) 2001-03-29 2002-03-26 Intimins in the prevention or treatment of infections:ii
AU2002241162A AU2002241162A1 (en) 2001-03-29 2002-03-26 Intimins in the prevention or treatment of infections:ii
PCT/GB2002/001447 WO2002079240A2 (en) 2001-03-29 2002-03-26 Intimins for the prevention or treatment of infections: i

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB0107837A GB0107837D0 (en) 2001-03-29 2001-03-29 Biological materials and methods for use in the prevention or treatment of infections:II

Publications (1)

Publication Number Publication Date
GB0107837D0 true GB0107837D0 (en) 2001-05-23

Family

ID=9911808

Family Applications (1)

Application Number Title Priority Date Filing Date
GB0107837A Ceased GB0107837D0 (en) 2001-03-29 2001-03-29 Biological materials and methods for use in the prevention or treatment of infections:II

Country Status (1)

Country Link
GB (1) GB0107837D0 (en)

Similar Documents

Publication Publication Date Title
AU2001293553A1 (en) Phosphatidylserine-carrying apoptosis-mimicking bodies and the use thereof in medical treatment
AU8870701A (en) Materials and methods for the treatment or prevention of obesity
HK1061212A1 (en) Pyranoindazoles and their use for the treatment ofglaucoma
EP1416961A4 (en) Composition and method for the treatment of disease
EP1689348A4 (en) Oligosaccharide compositions and use thereof in the treatment of infection
HK1089376A1 (en) Formulation for use in the prevention and treatment of carbohydrate induced ; diseases and conditions
EP1360965A4 (en) Methods of treating diseases in association with decrease in the expression of aop-1 gene or aop-1 and remedies for the diseases
EP1455778A4 (en) Methods for the treatment of peripheral neural and vascular ailments
AU2001283285A1 (en) Antimicrobial composition and methods of use in the treatment of disease
HUP0400069A3 (en) Pharmaceutical combinations and their use in preventing and treating the thrombosis
AU2002345255A1 (en) Composition comprising soy and use thereof in the prevention and/or treatment of various diseases
ZA200208228B (en) Use of il-18 inhibitors for the treatment and/or prevention of athesclerosis
IS6966A (en) Cyano-linked dihydropyrimidine compounds and their use in the treatment of diseases
IS6967A (en) New cyano-linked dihydropyrimidine compounds and their use in the treatment of diseases
GB0019302D0 (en) Biological materials and the use thereof for the treatment of disease
AU2002364171A8 (en) Materials and methods for the treatment or prevention of obesity
AU9279601A (en) Compounds and methods for use thereof in the treatment of cancer or viral infections
AU2002247973A1 (en) Use of epigallocatechin-3-gallate or its derivatives in the prevention and treatment of neurodegenerative diseases
HUP0302738A3 (en) Use of sarp-1 for the treatment and/or prevention of scleroderma
AU5565401A (en) Materials and methods for the treatment of depression
AU2002366195A8 (en) Use of bisindolmaleimide and gemcitabine for the treatment of cancer
EP1666046A4 (en) Use of n-acetyl-d-aminoglycosamine in preparation of drugs for the treatment of cacer and metastasis
GB0107837D0 (en) Biological materials and methods for use in the prevention or treatment of infections:II
GB0107840D0 (en) Biological materials and methods for use in the prevention or treatment of infections:I
AU2002241162A1 (en) Intimins in the prevention or treatment of infections:ii

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)